CompoAtlas

Richelet Protection Cellulaire Selenium ACE Optimum 50+

Food supplement declared in France, declaration No 2019-12-558

Richelet Protection Cellulaire Selenium ACE Optimum 50+ is a food supplement declared in France. Status: retiré du marché le 30 August 2026. 1 rule of use applies to its ingredients (limits and warnings).

Brand
not provided
Food business operator placing the product on the market
P&G Health France SAS
Status
Retiré du marché le 30 August 2026
Form
Comprimé
Daily dose
1 comprimé
Directions for use
1 comprimé par jour avec un verre d'eau
Not recommended for (according to the manufacturer)
Femmes enceintes, Sous traitement pour la thyroïde
Objectives stated by the manufacturer (these are not authorised claims)
Antioxydant

Declaration 166766, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Olea europaea subsp. europaeaFruitExtrait sec hydroalcoolique22.5 mg
Vitis vinifera L.PépinExtrait sec hydroalcoolique18.75 mg
Lycopersicon esculentum Mill.FruitOléorésine et gomme-oléorésine7.5 mg
Brassica oleracea L.PoussePoudre (de plantes séchées ou broyées)6.25 mg

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Levure enrichie en séléniumSélénium255 µg50 µg
Acide L-ascorbiqueVitamine Cpas de limite (données insuffisantes)180 mg
Acétate de DL-alpha-tocophéryleVitamine E300 mg30 mg

Additives

E341, E460, E551, E470b, E570, E464, E172, E553b, E468

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Ils est recommandés aux personnes ayant une hypothiroïdie ou un traitement de la thyroïde de consulter leur médecin (mention obligatoire en raison de la présence de brocoli).

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Olea europaea subsp. europaea
    Read the warning, when it applies and the studies cited

    OLIVE LEAF - OLEA EUROPAEA

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you pregnant or breastfeeding (EMA 2017).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a kidney disorder (EMA 2017).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking other diuretics (EMA 2017).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Condition of application: All products except those making a diuretic claim.

    When using this product diuretic effect may occur.

    Health Canada monograph dated 19 December 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line